The phrase "as offering additional" is correct and usable in written English.
It can be used when describing something that provides extra benefits or features in a particular context.
Example: "The new software update is being released as offering additional security features to protect user data."
Alternatives: "as providing extra" or "as presenting supplementary".
On the other hand, the emperor also saw monastic imprisonment as offering additional, historically unprecedented benefits over traditional domestic internment.
He has included links to articles about his potato salad "venture," as well as offering additional
More intensive recruitment and alternative recruitment strategies, such as offering additional incentives, may be necessary in remote areas to achieve participation rates comparable to areas located closer to the study centre.
A few single markers may individually produce small p values and results from some multimarker methods, using logistic regression or inferred haplotypes, may be presented as offering additional support.
Indeed, the increasing similarities between marriage and its alternatives — what has been termed the "blurred boundaries" between cohabitation and marriage in function, social acceptance, and legal treatment (Musick and Bumpass 2011) — can be read as offering additional evidence for the deinstitutionalization of marriage.
The intervention program consisted of an individual classroom-based component (i.e. an educational program, covering 11 lessons of both biology and physical education classes), and an environmental component (i.e. encouraging and supporting changes at the school canteens, as well as offering additional physical education classes).
Later, Cerami found that HbA1c levels reflected urine glucose levels in humans as well (8), offering additional evidence that the HbA1c may be a helpful tool for people with diabetes.
Alternative app stores for Android have been created by companies such as Amazon, offering additional curation and more vigorous checks.
Our 180-gene GEPR classified this patient as 'sensitive', offering additional support of the independency of our test from KRAS mutational status.
Motesanib inhibits VEGFR1, VEGFR-2, and VEGFR-3 as well as PDGFR and Kit, potentially offering additional benefit not only by blocking angiogenesis but also by reducing lymphangiogenesis, and potentially tumor growth [ 28– 31].
Several other studies have also shown that the transdermal delivery of rivastigmine allows more patients to reach and maintain the therapeutic dose, offering additional therapeutic benefits as well as contributing to improved treatment compliance.
